APP and Alzheimer disease: These dynamic epifluorescence imaging results intuitively suggested that probe 9 could rapidly cross the BBB and efficiently label both the parenchymal and angiopathic Aβ plaques in APP/PS1 AD mouse, not WT mouse, supporting the high potential of our designed probes for noninvasively detecting Aβ deposits in vivo.